439 related articles for article (PubMed ID: 10760364)
21. Additive reduction of alcohol drinking by 5-HT1A antagonist WAY 100635 and serotonin uptake blocker fluoxetine in alcohol-preferring P rats.
Zhou FC; McKinzie DL; Patel TD; Lumeng L; Li TK
Alcohol Clin Exp Res; 1998 Feb; 22(1):266-9. PubMed ID: 9514317
[TBL] [Abstract][Full Text] [Related]
22. Rapid desensitization of 5-HT(1A) receptors in Fawn-Hooded rats after chronic fluoxetine treatment.
Kantor S; Graf M; Anheuer ZE; Bagdy G
Eur Neuropsychopharmacol; 2001 Feb; 11(1):15-24. PubMed ID: 11226808
[TBL] [Abstract][Full Text] [Related]
23. Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex.
Invernizzi R; Bramante M; Samanin R
Pharmacol Biochem Behav; 1996 May; 54(1):143-7. PubMed ID: 8728551
[TBL] [Abstract][Full Text] [Related]
24. Chronic fluoxetine treatment selectively uncouples raphe 5-HT(1A) receptors as measured by [(35)S]-GTP gamma S autoradiography.
Pejchal T; Foley MA; Kosofsky BE; Waeber C
Br J Pharmacol; 2002 Mar; 135(5):1115-22. PubMed ID: 11877317
[TBL] [Abstract][Full Text] [Related]
25. Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat.
Lucas G; Du J; Romeas T; Mnie-Filali O; Haddjeri N; Piñeyro G; Debonnel G
PLoS One; 2010 Feb; 5(2):e9253. PubMed ID: 20169084
[TBL] [Abstract][Full Text] [Related]
26. The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.
Rasmussen K; Calligaro DO; Czachura JF; Dreshfield-Ahmad LJ; Evans DC; Hemrick-Luecke SK; Kallman MJ; Kendrick WT; Leander JD; Nelson DL; Overshiner CD; Wainscott DB; Wolff MC; Wong DT; Branchek TA; Zgombick JM; Xu YC
J Pharmacol Exp Ther; 2000 Aug; 294(2):688-700. PubMed ID: 10900249
[TBL] [Abstract][Full Text] [Related]
27. Involvement of serotonin in the modulation of cocaine-induced locomotor activity in the rat.
Herges S; Taylor DA
Pharmacol Biochem Behav; 1998 Mar; 59(3):595-611. PubMed ID: 9512061
[TBL] [Abstract][Full Text] [Related]
28. Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C/2B) receptor antagonists: neurochemical and behavioural studies.
Hutson PH; Barton CL; Jay M; Blurton P; Burkamp F; Clarkson R; Bristow LJ
Neuropharmacology; 2000 Sep; 39(12):2318-28. PubMed ID: 10974315
[TBL] [Abstract][Full Text] [Related]
29. 5-HT1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats.
Moser PC; Sanger DJ
Eur J Pharmacol; 1999 May; 372(2):127-34. PubMed ID: 10395092
[TBL] [Abstract][Full Text] [Related]
30. The effects of antipsychotics with 5-HT(2C) receptor affinity in behavioral assays selective for 5-HT(2C) receptor antagonist properties of compounds.
Prinssen EP; Koek W; Kleven MS
Eur J Pharmacol; 2000 Jan; 388(1):57-67. PubMed ID: 10657547
[TBL] [Abstract][Full Text] [Related]
31. Effect of SB-243213, a selective 5-HT(2C) receptor antagonist, on the rat sleep profile: a comparison to paroxetine.
Smith MI; Piper DC; Duxon MS; Upton N
Pharmacol Biochem Behav; 2002 Apr; 71(4):599-605. PubMed ID: 11888551
[TBL] [Abstract][Full Text] [Related]
32. Modulation of the subthalamic nucleus activity by serotonergic agents and fluoxetine administration.
Aristieta A; Morera-Herreras T; Ruiz-Ortega JA; Miguelez C; Vidaurrazaga I; Arrue A; Zumarraga M; Ugedo L
Psychopharmacology (Berl); 2014 May; 231(9):1913-24. PubMed ID: 24271033
[TBL] [Abstract][Full Text] [Related]
33. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.
Gobert A; Millan MJ
Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475
[TBL] [Abstract][Full Text] [Related]
34. EMD 68843, a serotonin reuptake inhibitor with selective presynaptic 5-HT1A receptor agonistic properties.
Bartoszyk GD; Hegenbart R; Ziegler H
Eur J Pharmacol; 1997 Mar; 322(2-3):147-53. PubMed ID: 9098681
[TBL] [Abstract][Full Text] [Related]
35. Serotonin 1B and 2C receptor interactions in the modulation of feeding behaviour in the mouse.
Dalton GL; Lee MD; Kennett GA; Dourish CT; Clifton PG
Psychopharmacology (Berl); 2006 Mar; 185(1):45-57. PubMed ID: 16470405
[TBL] [Abstract][Full Text] [Related]
36. Electroencephalographic activation by fluoxetine in rats: role of 5-HT(1A) receptors and enhancement of concurrent acetylcholinesterase inhibitor treatment.
Dringenberg HC; Diavolitsis P
Neuropharmacology; 2002 Feb; 42(2):154-61. PubMed ID: 11804611
[TBL] [Abstract][Full Text] [Related]
37. The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used.
Lucas G; De Deurwaerdère P; Caccia S; Umberto Spampinato
Neuropharmacology; 2000 Apr; 39(6):1053-63. PubMed ID: 10727716
[TBL] [Abstract][Full Text] [Related]
38. Role of 5-HT(2a) and 5-HT(2B/2C) receptors in the behavioral interactions between serotonin and catecholamine reuptake inhibitors.
McMahon LR; Cunningham KA
Neuropsychopharmacology; 2001 Mar; 24(3):319-29. PubMed ID: 11166521
[TBL] [Abstract][Full Text] [Related]
39. Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse.
Knobelman DA; Hen R; Blendy JA; Lucki I
J Pharmacol Exp Ther; 2001 Sep; 298(3):1092-100. PubMed ID: 11504806
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
van Amsterdam C; Seyfried CA
Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
